Effect of the combination of orlistat and l-carnitine on the quality of life (sf-36) in 16 overweigth patients. a preliminary result

Effect of the combination of orlistat and l-carnitine on the quality of life (sf-36) in 16 overweigth patients. a preliminary result

Introduction and Objectives: Orlistat is a drug widely used in overweight/obese patients, while the combination with l-carnitine could offer an improvement in its effectiveness. To our knowledge, the effect of this combination on the quality of life of overweight patients has not been determined.To...

Full description

Bibliographic Details
Main Authors:	Saúl A. Vera-Nungaray, Miguel Y. Carmona-Castillo, María F. Higuera-de la Tijera, Livan Delgado-Roche, Evelyn Altamirano-Castillo, Nancy G. Vega-López, Uriel Gutiérrez-Estrada, Santiago Camacho-Hernández
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124002643

Similar Items

Medical management of obesity and overweigth in childhood
by: Carmen Emilia Guerra Cabrera, et al.
Published: (2009-03-01)

Medical management of obesity and overweigth in childhood
by: Carmen Emilia Guerra Cabrera, et al.
Published: (2009-03-01)

36 year old man presenting with pancreatitis and a history of recent commencement of orlistat case report
by: Thomas Matthew, et al.
Published: (2006-08-01)

[Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components].
by: Vilagut, G, et al.
Published: (2008)

Obesity management: Update on orlistat
by: Belinda S Drew, et al.
Published: (2008-01-01)

FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36
by: Exley, A, et al.
Published: (1995)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

Acute oxalate nephropathy associated with orlistat
by: Youshay Humayun, et al.
Published: (2016-04-01)

Orlistat in the prevention of diabetes in the obese patient
by: Marcio C Mancini, et al.
Published: (2008-04-01)

SF-36 questionnaire and its utilization in rheumatoid arthritis
by: Sh Erdes, et al.
Published: (2003-04-01)

Psychometric Properties of the Short Form-36 (SF-36) in Parents of Children with Mental Illness
by: Madeline Reed, et al.
Published: (2022-05-01)

Validity of short form 36 (SF-36) Indonesian version on rheumatoid arthritis patients
by: Laras Novitasari, et al.
Published: (2016-06-01)

Development and validation by statistical treatment of stability indicating RP-HPLC method for quantification of Orlistat in Orlistat-loaded solid dispersion
by: Kiran Singh Sharma, et al.
Published: (2021-02-01)

<b>High blood pressure, overweigth and abdominal obesity in children and adolescents</b> - doi: 10.4025/reveducfis.v22i4.10486
by: Deise Cristiane Moser, et al.
Published: (2012-01-01)

Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population
by: Akvardar Yildiz, et al.
Published: (2006-10-01)

Efficacy of Orlistat on Hyperbilirubinemia in Full Term Neonates
by: M Habibi, et al.
Published: (2024-03-01)

Orlistat improves endothelial function in obese adolescents
Published: (2013-12-01)

SF-36 questionnaire population quality of life indices Objective
by: V N Amirdjanova, et al.
Published: (2008-02-01)

Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study
by: Lix Lisa M, et al.
Published: (2012-03-01)

POSSIBILITIES OF APPLICATION OF THE ADAPTED SF-36 QUESTIONNAIRE IN THE PEDIATRIC POPULATION
by: Сергей Иванович Головкин, et al.
Published: (2017-11-01)

Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1
by: Cunningham William E, et al.
Published: (2007-09-01)

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
by: Walton Surrey M, et al.
Published: (2005-03-01)

Effect of orlistat on obese women with polycystic ovary syndrome
by: Qi Jiang, et al.
Published: (2018-12-01)

The effect of orlistat treatment on cardiovascular novel inflammatory biomarkers
by: Zafer Yalim, et al.
Published: (2020-06-01)

ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES
by: A. M. Mkrtumyan, et al.
Published: (2017-12-01)

High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.
by: Juliane Hahn, et al.
Published: (2013-01-01)

The effect of orlistat on body weight in obese Czech adults
by: Pavlík Vladimír, et al.
Published: (2013-10-01)

Evaluation of quality of life in patients with systemic sclerosis by the SF-36 questionnaire
by: R. Cossutta, et al.
Published: (2002-06-01)

Convergent validity between SF-36 and WHOQOL-BREF in older adults
by: Paula Costa Castro, et al.
Published: (2014-02-01)

Validity of the SF-36 Health Survey Questionnaire in Two Iranian Samples
by: Mohammadali Asghari Moghaddam, et al.
Published: (2003-11-01)

A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?
by: Jenkinson, C, et al.
Published: (1997)

Qualidade de vida em pacientes com osteoporose: correlação entre OPAQ e SF-36 Quality of life in patients with osteoporosis: correlation between OPAQ and SF-36
by: Maria Carolina Davel Lemos, et al.
Published: (2006-10-01)

Comparação entre DASH e SF-36 do cotovelo traumatizado reabilitado na terapia ocupacional Comparison between DASH and SF-36 of the injured elbow rehabilitated in occupational therapy
by: Márcia Regina Papp, et al.
Published: (2011-01-01)

Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México Health status evaluation with the SF-36 Survey: preliminary results in Mexico
by: Miguel A. Zúniga, et al.
Published: (1999-03-01)

RELATIONSHIPS BETWEEN SF-36 AND BONE MINERAL DENSITY: THE HERTFORDSHIRE COHORT STUDY
by: Dennison, E, et al.
Published: (2004)

The SF-36: a simple, effective measure of mobility-disability for epidemiological studies.
by: Syddall, H, et al.
Published: (2009)

Comparison of UK and US methods for weighting and scoring the SF-36 summary measures.
by: Jenkinson, C
Published: (1999)

Reliability and Validity of the Chinese Version of SF-36 Scale in Guangdong Occupational Rehabilitation
by: Huiling ZHOU, et al.
Published: (2018-06-01)

Assessment of quality oflife in patients with early knee osteoarthritis using SF-36
by: M S Svetlova, et al.
Published: (2007-10-01)

Quality of life in patients with juvenile arthritis (according to the data of the SF-36 questionnaire)
by: Tat'yana Andreevna Shelepina, et al.
Published: (2011-06-01)